Situation: A mid-sized biopharma company acquires an FDA-approved brand for the treatment of anemia. The company has little experience in the therapeutic category and no commercialization plan in place. Meanwhile, the brand is struggling with less-than-optimal prescription rates. The company needs a plan to relaunch the brand quickly, and they need additional resources to support it on the market.
Insight: inVentiv's team of strategists conduct a series of analytical and research studies to better understand the current state of the anemia category, the competitive set, and the potential opportunity for the brand. With a clear understanding of the market gaps, the team crafts a commercialization plan to position the brand for maximum success on the market.
Solution: Using the new commercialization plan as a foundation, inVentiv develops an integrated sales and marketing program with the following components:
Results: The company records incremental ROI on the program within the first few months as both product awareness and prescription rates among targeted physicians grow.